Ashir Mehra

Ashir Mehra


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AMAshir Mehra
Ashir Mehra
FRFrancisco Eduardo Gomez Romero
Francisco Eduardo Gomez Romero
Holly BischofHolly Bischof
Holly Bischof
DDDaniel Diedrich
Daniel Diedrich
Krzysztof LaudanskiKrzysztof Laudanski
Krzysztof Laudanski
Poor outcomes in Subarachnoid Hemorrhage (SAH) are in part due to a unique form of secondary neurological injury known as Delayed Cerebral Ischemia (DCI). DCI is characterized by new neurological insults that continue to occur beyond 72 h after the onset of the hemorrhage. Historically, it was thought to be a consequence of hypoperfusion in the setting of vasospasm. However, DCI was found to occur even in the absence of radiographic evidence of vasospasm. More recent evidence indicates that catastrophic ionic disruptions known as Cortical Spreading Depolarizations (CSD) may be the culprits of DCI. CSDs occur in otherwise healthy brain tissue even without demonstrable vasospasm. Furthermore, CSDs often trigger a complex interplay of neuroinflammation, microthrombi formation, and vasoconstriction. CSDs may therefore represent measurable and modifiable prognostic factors in the prevention and treatment of DCI. Although Ketamine and Nimodipine have shown promise in the treatment and prevention of CSDs in SAH, further research is needed to determine the therapeutic potential of these as well as other agents.

30 August 2023 in Frontiers in Neuroscience
Verified
Journal Article
Open access
FGFrancisco Gomez
Francisco Gomez
AMAshir Mehra
Ashir Mehra
EEErik Ensrud
Erik Ensrud
DDDaniel Diedrich
Daniel Diedrich
KLKrzysztof Laudanski
Krzysztof Laudanski
COVID-19 infection has had a profound impact on society. During the initial phase of the pandemic, there were several suggestions that COVID-19 may lead to acute and protracted neurologic sequelae. For example, peripheral neuropathies exhibited distinctive features as compared to those observed in critical care illness. The peripheral nervous system, lacking the protection afforded by the blood–brain barrier, has been a particular site of sequelae and complications subsequent to COVID-19 infection, including Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy. We will discuss these disorders in terms of their clinical manifestations, diagnosis, and treatment as well as the pathophysiology in relation to COVID-19.

12 March 2024 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
MIMaxwell Isaac
Maxwell Isaac
SKSenthil A. Kumar
Senthil A. Kumar
GPGregory F. Petroski
Gregory F. Petroski
ASAlex Shinn
Alex Shinn
AMAshir Mehra
Ashir Mehra
CMCamilo R. MBA
Camilo R. MBA